Antibiotic resistance in cancer patients

作者：Gudiol Carlota^*; Carratala Jordi

来源：Expert Review of Anti-Infective Therapy, 2014, 12(8): 1003-1016.

DOI：10.1586/14787210.2014.920253

• antibiotic resistance
• antibiotic therapy
• bacterial infection
• cancer
• mortality
• neutropenia
• prognosis

Bacterial infection is one of the most frequent complications in cancer patients and hematopoietic stem cell transplant recipients. In recent years, the emergence of antimicrobial resistance has become a significant problem worldwide, and cancer patients are among those affected. Treatment of infections due to multidrug-resistant (MDR) bacteria represents a clinical challenge, especially in the case of Gram-negative bacilli, since the therapeutic options are often very limited. As the antibiotics active against MDR bacteria present several disadvantages (limited clinical experience, higher incidence of adverse effects, and less knowledge of the pharmacokinetics of the drug), a thorough acquaintance with the main characteristics of these drugs is mandatory in order to provide safe treatment to cancer patients with MDR bacterial infections. Nevertheless, the implementation of antibiotic stewardship programs and infection control measures is the cornerstone for controlling the development and spread of these MDR pathogens.

• 出版日期2014-8